Independent directory Public ClinicalTrials.gov records United States
Clear filters

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:16 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–5 of 5 matching trials from the live ClinicalTrials.gov search.
Conditions
Non-Small Cell Lung Cancer
Interventions
Not listed
Lead sponsor
Inivata
Industry
Eligibility
18 Years and older
Enrollment
264 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2016 – 2018
U.S. locations
35
States / cities
Mission Hills, California • Aurora, Colorado • Norwich, Connecticut + 32 more
Completed Not applicable Interventional Results available

THRIVE Breast Cancer App Study

NCT03592771
Conditions
Breast Neoplasm Female
Interventions
THRIVE App, Tailored Feedback Messages
Behavioral
Lead sponsor
Emory University
Other
Eligibility
18 Years to 110 Years · Female only
Enrollment
304 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2018 – 2022
U.S. locations
2
States / cities
Memphis, Tennessee
Conditions
Liposarcoma, Surgically Unresectable Liposarcoma, Metastatic Liposarcoma
Interventions
pazopanib
Drug
Lead sponsor
Vector Oncology
Other
Eligibility
18 Years and older
Enrollment
42 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2012 – 2016
U.S. locations
9
States / cities
Santa Monica, California • Washington D.C., District of Columbia • Post Falls, Idaho + 6 more
Conditions
Gynecologic Tumors
Interventions
Oral Topotecan, Pazopanib
Drug
Lead sponsor
Vector Oncology
Other
Eligibility
18 Years and older · Female only
Enrollment
33 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2009 – 2015
U.S. locations
1
States / cities
Memphis, Tennessee
Conditions
HER-2 Positive Breast Cancer
Interventions
eribulin, carboplatin, trastuzumab
Drug
Lead sponsor
Vector Oncology
Other
Eligibility
18 Years and older · Female only
Enrollment
12 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2011 – 2014
U.S. locations
4
States / cities
Fort Lauderdale, Florida • Athens, Georgia • Marietta, Georgia + 1 more